Earnings History Data for ImmuCell Corporation (ICCC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ImmuCell Corporation
ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | ICCC | ImmuCell Corporation | 27.65 | -0.09 | 0.00 | -0.12 | ImmuCell GAAP EPS of -$0.09, revenue of $6.01M [11/13/2024 4:11 PM] |
3.57 | 0.04 (1.13%) |
0.0 | 0.0 (0.00%) |
3.34 - 5.59 | 17,164 | 20,000 | 0 | ||
| 13-08-2024 | PM | ICCC | ImmuCell Corporation | 29.45 | -0.20 | 0.00 | -0.18 | ImmuCell GAAP EPS of -$0.20, revenue of $5.5M [8/14/2024 11:39 AM] |
3.60 | -0.16 (-4.26%) |
3.61 | -0.15 (-3.99%) |
3.50 - 5.64 | 5,424 | 10,000 | 366 | ||
| 14-05-2024 | AH | ICCC | ImmuCell Corporation | 42.16 | -0.06 | 0.00 | -0.30 | ImmuCell reports Q1 results [5/14/2024 4:48 PM] |
4.90 | -0.58 (-10.55%) |
0.0 | 0.0 (0.00%) |
4.34 - 6.05 | 66,937 | 10,000 | 0 | ||
| 27-02-2024 | AH | ICCC | ImmuCell Corporation | 39.84 | -0.15 | 0.00 | -0.22 | ImmuCell GAAP EPS of -$0.15, revenue of $5.09M [2/27/2024 4:23 PM] |
5.22 | 0.08 (1.56%) |
0.0 | 0.0 (0.00%) |
4.26 - 6.16 | 7,570 | 10,000 | 0 | ||
| 13-11-2023 | AH | ICCC | ImmuCell Corporation | 42.30 | -0.12 | 0.00 | -0.08 | ImmuCell GAAP EPS of -$0.12, revenue of $5.39M [11/13/2023 4:23 PM] |
5.30 | 0.10 (1.92%) |
0.0 | 0.0 (0.00%) |
4.26 - 8.48 | 9,269 | 10,000 | 0 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
ICCC | ImmuCell Corporation | 37.96 | -0.30 | 0.00 | 0.09 | ImmuCell GAAP EPS of -$0.30, revenue of $2.6M [5/11/2023 4:29 PM] |
4.64 | -0.32 (-6.46%) |
4.61 | -0.35 (-7.06%) |
4.26 - 9.60 | 26,636 | 0 | 147 | |
| 21-02-2023 | AH | 4:05 PM ET (Feb 21) |
ICCC | ImmuCell Corporation | 55.39 | -0.22 | 0.00 | 0.01 | ImmuCell GAAP EPS of -$0.32, revenue of $18.57M [2/21/2023 4:24 PM] |
6.81 | -0.50 (-6.84%) |
0.0 | 0.0 (0.00%) |
5.98 - 10.96 | 25,527 | 10,000 | 0 | |
| 11-08-2022 | AH | 4:05 PM ET (Aug 11) |
ICCC | ImmuCell Corporation | 65.19 | -0.09 | 0.00 | 0.02 | ImmuCell GAAP EPS of -$0.09, revenue of $3.86M [8/11/2022 4:26 PM] |
8.15 | -0.60 (-6.86%) |
0.0 | 0.0 (0.00%) |
7.30 - 10.96 | 37,833 | 10,000 | 0 | |
| 12-05-2022 | AH | 4:05 PM ET (May 13) |
ICCC | ImmuCell Corporation | 62.02 | 0.09 | 0.00 | -0.06 | ImmuCell reports Q1 results [5/12/2022 4:11 PM] |
8.29 | 0.49 (6.30%) |
7.82 | 0.02 (0.26%) |
7.30 - 10.96 | 9,569 | 20,000 | 513 | |
| 22-02-2022 | AH | 4:05 PM ET (Feb 22) |
ICCC | ImmuCell Corporation | 65.50 | 0.01 | 0.00 | 0.03 | ImmuCell GAAP EPS of -$0.01 beats by $0.10, revenue of $19.24M beats by $2.59M [2/22/2022 4:43 PM] |
8.11 | 0.11 (1.40%) |
0.0 | 0.0 (0.00%) |
7.30 - 12.02 | 8,637 | 10,000 | 0 | |
| 15-11-2021 | AH | 4:05 PM ET (Nov 15) |
ICCC | ImmuCell Corporation | 71.30 | 0.02 | 0.00 | -0.04 | ImmuCell reports Q3 results [11/15/2021 4:26 PM] |
9.20 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
5.41 - 13.20 | 7,525 | 0 | 0 | |
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
ICCC | ImmuCell Corporation | 73.53 | 0.02 | 0.00 | -0.11 | ImmuCell reports Q2 results [8/12/2021 4:41 PM] |
9.01 | -0.33 (-3.49%) |
0.0 | 0.0 (0.00%) |
5.01 - 13.20 | 11,805 | 0 | 0 | |
| 13-05-2021 | AH | 4:00 PM ET (May 13) |
ICCC | ImmuCell Corporation | 72.72 | -0.06 | 0.00 | -0.02 | ImmuCell reports Q1 results [5/13/2021 4:15 PM] |
9.78 | 0.57 (6.19%) |
0.0 | 0.0 (0.00%) |
3.80 - 13.20 | 17,890 | 20,000 | 0 | |
| 22-02-2021 | AH | 4:05 PM ET (Feb 22) |
ICCC | ImmuCell Corporation | 82.37 | 0.03 | 0.00 | -0.06 | ImmuCell EPS beats by $0.10, beats on revenue [2/22/2021 4:06 PM] |
10.47 | -1.27 (-10.82%) |
11.00 | -0.74 (-6.30%) |
3.70 - 13.20 | 107,684 | 54,805 | 1,430 | |
| 12-11-2020 | AH | 4:05 PM ET (Nov 12) |
ICCC | ImmuCell Corporation | 39.45 | -0.04 | 0.00 | -0.07 | ImmuCell EPS beats by $0.04, beats on revenue [11/12/2020 4:14 PM] |
5.75 | 0.07 (1.23%) |
0.0 | 0.0 (0.00%) |
3.70 - 8.13 | 12,013 | 9,018 | 0 | |
|
|
||||||||||||||||||
| 12-08-2020 | AH | 4:05 PM ET (Aug 12) |
ICCC | ImmuCell Corporation | 41.76 | -0.11 | 0.00 | -0.09 | ImmuCell EPS misses by $0.01, misses on revenue [8/12/2020 4:07 PM] |
5.55 | -0.15 (-2.63%) |
0.0 | 0.0 (0.00%) |
3.70 - 8.13 | 9,291 | 18,497 | 0 | |
|
|
||||||||||||||||||